90 related articles for article (PubMed ID: 26643423)
21. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
Castro FA; Haimila K; Sareneva I; Schmitt M; Lorenzo J; Kunkel N; Kumar R; Försti A; Kjellberg L; Hallmans G; Lehtinen M; Hemminki K; Pawlita M
Int J Cancer; 2009 Oct; 125(8):1851-8. PubMed ID: 19585495
[TBL] [Abstract][Full Text] [Related]
22. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore.
Ceschi M; Sun CL; Van Den Berg D; Koh WP; Yu MC; Probst-Hensch N
Carcinogenesis; 2005 Aug; 26(8):1457-64. PubMed ID: 15845652
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
[TBL] [Abstract][Full Text] [Related]
24. CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.
Lu C; Dong J; Ma H; Jin G; Hu Z; Peng Y; Guo X; Wang X; Shen H
Breast Cancer Res Treat; 2009 Aug; 116(3):571-5. PubMed ID: 18819000
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity.
El Menshawy N; El Marghany AB; Sarhan MM; Aladle DA
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2941-2947. PubMed ID: 33112552
[TBL] [Abstract][Full Text] [Related]
26. Association of cyclin D1 variants with head and neck cancer susceptibility: evidence from a meta-analysis.
Lin H; Fang L; Lin D
Asian Pac J Cancer Prev; 2014; 15(14):5645-51. PubMed ID: 25081680
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women.
Jeon YT; Kim JW; Song JH; Park NH; Song YS; Kang SB; Lee HP
Cancer Lett; 2005 Jun; 223(2):259-63. PubMed ID: 15896460
[TBL] [Abstract][Full Text] [Related]
28. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
[TBL] [Abstract][Full Text] [Related]
29. Association between cyclin D1 (CCND1) polymorphism and gastric cancer risk in Japanese population.
Tahara T; Arisawa T; Shibata T; Yamashita H; Hirata I
Hepatogastroenterology; 2009; 56(93):1232-5. PubMed ID: 19760977
[TBL] [Abstract][Full Text] [Related]
30. CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
Tang C; Wang Z; Yu J; Wu Y; Zhu Z; Chen N
Med Oncol; 2011 Dec; 28(4):1319-24. PubMed ID: 20443083
[TBL] [Abstract][Full Text] [Related]
31. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
[TBL] [Abstract][Full Text] [Related]
32. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
Li J; Luo F; Zhang H; Li L; Xu Y
Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
[TBL] [Abstract][Full Text] [Related]
33. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.
Hong Y; Eu KW; Seow-Choen F; Fook-Chong S; Cheah PY
Eur J Cancer; 2005 May; 41(7):1037-44. PubMed ID: 15862753
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry.
Bachmann K; Neumann A; Hinsch A; Nentwich MF; El Gammal AT; Vashist Y; Perez D; Bockhorn M; Izbicki JR; Mann O
J Surg Oncol; 2015 Mar; 111(3):316-23. PubMed ID: 25470788
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
36. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
[TBL] [Abstract][Full Text] [Related]
38. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
Wang S; Huang Y; Su R; Fang Z; Han M
Genet Mol Res; 2015 Jun; 14(2):5856-61. PubMed ID: 26125784
[TBL] [Abstract][Full Text] [Related]
40. CCND1 G870A polymorphism is associated with toxicity of methotrexate in childhood acute lymphoblastic leukemia.
Xue Y; Rong L; Tong N; Wang M; Zhang Z; Fang Y
Int J Clin Exp Pathol; 2015; 8(9):11594-600. PubMed ID: 26617896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
